TrialNature communications2026

LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial.

O Hamid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.